|
Volumn 21, Issue 7, 2001, Pages 444-450
|
Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations
a b b b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
INDOMETACIN;
MAGNESIUM;
NIFEDIPINE;
TERBUTALINE;
UTERUS SPASMOLYTIC AGENT;
ADULT;
ARTICLE;
BIRTH WEIGHT;
COHORT ANALYSIS;
COMPARATIVE STUDY;
CONTINUOUS INFUSION;
CONTROLLED STUDY;
COST;
COST EFFECTIVENESS ANALYSIS;
DATA BASE;
DELIVERY;
DRUG COST;
FEMALE;
GESTATIONAL AGE;
HOSPITAL CHARGE;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MODEL;
NEWBORN;
NEWBORN INTENSIVE CARE;
NURSERY;
OUTCOMES RESEARCH;
OUTPATIENT;
PERINATAL PERIOD;
PREMATURE LABOR;
RECURRENT DISEASE;
RETROSPECTIVE STUDY;
TWIN PREGNANCY;
ADMINISTRATION, ORAL;
COHORT STUDIES;
COST-BENEFIT ANALYSIS;
FEMALE;
HOME INFUSION THERAPY;
HOSPITAL CHARGES;
HUMANS;
INFANT, NEWBORN;
INFUSIONS, PARENTERAL;
OBSTETRIC LABOR, PREMATURE;
PREGNANCY;
PREGNANCY OUTCOME;
RECURRENCE;
RETROSPECTIVE STUDIES;
TERBUTALINE;
TOCOLYTIC AGENTS;
TWINS;
|
EID: 0034780107
PISSN: 07438346
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.jp.7210553 Document Type: Article |
Times cited : (19)
|
References (25)
|